Investor Presentaiton
In Summary
1
Medlab acquisition forms part of well-defined strategic growth plan and has complementary geographic footprint
2 Acquisition will further strengthen ACL's national scale
3
Will deliver both significant growth opportunities and shareholder value
4
Additional scale to underpin further operating leverage
5
ACL has demonstrated a proven track record in integrating acquisitions to deliver shareholder value
6
7
Post acquisition, ACL will have histology labs in each State in which it operates, including leading skin and
gastroenterology specialist to further support ACL's strength in these areas
ACL Travel Testing Portal now live to support travellers as international borders open up
8 Medlab acquisition to strategically assist ACL in targeting emerging private COVID traveller market
11View entire presentation